Skip to main content

Jeffrey Rathmell Archives

Waddell Walker Hancock Cancer Discovery Fund names first scholars

Feb. 16, 2024—A research endeavor that seeks to develop a new cancer immunotherapy utilizing nanobody delivery and targeted heating of tumors has received funding from the Waddell Walker Hancock Cancer Discovery Fund.

Read more


Twelve at Vanderbilt are among world’s highly cited researchers

Nov. 15, 2023—Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers.

Read more


Vanderbilt-led team receives 2023 Endeavor Award from The Mark Foundation for Cancer Research

Oct. 24, 2023—A multidisciplinary team of investigators has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research to support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection,

Read more


Study identifies potential new approach for treating lupus

Jan. 13, 2023—A Vanderbilt study found that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus — the most common form of the chronic autoimmune disease lupus.

Read more


Several from VUMC among most highly cited researchers

Nov. 17, 2022—Nine current faculty members of the Vanderbilt University School of Medicine have made this year’s list of scientists whose papers have been cited most frequently by other researchers.

Read more


Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine

Jul. 20, 2022—In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.

Read more


Faculty awards honor teaching, clinical, research excellence

May. 5, 2022—The 2022 Vanderbilt University School of Medicine Academic Enterprise Awards for Excellence in Teaching, Extraordinary Performance of Clinical Service, and Outstanding Contributions to Research were presented April 29 during the annual spring faculty meeting.

Read more


CRISPR screen identifies new anti-inflammatory drug target

Nov. 11, 2021—A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics.

Read more


VICC researchers featured at AACR Annual Meeting

Apr. 8, 2021—Researchers from Vanderbilt-Ingram Cancer Center will have a robust presence during the first session of the American Association for Cancer Research (AACR) Annual Meeting, April 10-15, as presenters, panelists and authors.

Read more


Study revises understanding of cancer metabolism

Apr. 7, 2021—Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years.

Read more


Rathmell lands award from Lupus Research Alliance

Oct. 31, 2019—Jeffrey Rathmell, PhD, is a 2019 recipient of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity.

Read more


Center for Immunobiology grows, bolsters program

Jul. 18, 2019—The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more